Astera Labs, Inc. Common Stock cash flow to debt ratio of 908.49% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.

Astera Labs, Inc. Common Stock's free cash flow has increased 175.07% from $102.43M last year to $281.76M, signaling increasing performance

Astera Labs, Inc. Common Stock's debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability.

Astera Labs, Inc. Common Stock's debt has decreased relative to shareholder equity from 0.00 last year to 0.00 today, signaling strengthened financials

Astera Labs, Inc. Common Stock has a net cash position, so leverage is healthy.

Astera Labs, Inc. Common Stock earns at least as much interest as it pays. Interest obligations are fully covered.

Astera Labs, Inc. Common Stock's profit margin has increased (-246.04%) in the last year from -21.05% to 30.74%, signaling increasing performance

Astera Labs, Inc. Common Stock's short-term assets of $1.36B exceed its short-term liabilities of $133.04M

Astera Labs, Inc. Common Stock's return on assets of 19.13% is higher than the 5.00% threshold, indicating efficient asset utilization

Astera Labs, Inc. Common Stock's return on equity of 25.24%, is higher than 15.00%, indicating good performance

Astera Labs, Inc. Common Stock's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Astera Labs, Inc. Common Stock has insufficient public price history to evaluate earnings stability.

Astera Labs, Inc. Common Stock has positive free cash flow, indicating the company generates cash after capital expenditures

Astera Labs, Inc. Common Stock has a free cash flow yield of 0.52%, which is below the 2.00% threshold, indicating limited cash return relative to market value

Astera Labs, Inc. Common Stock's yearly earnings has increased -362.68% since last year from $-83.42M to $219.13M, signaling increasing performance

Astera Labs, Inc. Common Stock's yearly revenue has increased 115.13% since last year from $396.29M to $852.52M, signaling increasing performance

ROIC 15.47% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

Astera Labs, Inc. Common Stock's 3-year revenue CAGR of 120.18% is positive, indicating growing revenue over the past 3 years

Astera Labs, Inc. Common Stock has insufficient public price history to evaluate revenue consistency.

Astera Labs, Inc. Common Stock has insufficient public price history to evaluate ROE consistency.

Astera Labs, Inc. Common Stock has insufficient data to evaluate this check.

Astera Labs, Inc. Common Stock has an earnings yield of 0.68%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

Astera Labs, Inc. Common Stock is overvalued relative to its fair value price of 10.04 based on EBITDA multiple model

Astera Labs, Inc. Common Stock has an EV/EBITDA ratio of 236.56x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings

Astera Labs, Inc. Common Stock has insufficient data to evaluate this check.

Astera Labs, Inc. Common Stock has insufficient diluted EPS history to calculate the PEG ratio.

Astera Labs, Inc. Common Stock has a price-to-book ratio of 31.54x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Astera Labs, Inc. Common Stock has a price-to-sales ratio of 45.28x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue